Serial 88304145
Live / Registered — Registered (as of 15 Mar 2022)
What this means for you
Registered since 15 Mar 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88304145
- Registration number
- 6672522
- Mark type
- Design / logo
- Filed
- 15 Feb 2019
- Published for opposition
- 04 Jun 2019
- Registered
- 15 Mar 2022
- Attorney of record
- Hayley J. Talbert
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals for the treatment of rare diseases; research and development for the treatment of hypertension, kidney stones, gallstones, cholesterol, rage disorders, lactation, schizophrenia, autism, kidney disease, neurodegeneration, infantile spasms, nephrotic syndrome, muscular dystrophy, and diabetic nephropathy
Owner
- TRAVERE THERAPEUTICS, INC., SAN DIEGO, CA, US
- TRAVERE THERAPEUTICS, INC., SAN DIEGO, CA, US
- Retrophin, Inc., San Diego, CA, US
- Retrophin, Inc., San Diego, CA, US
Prosecution history
- 15 Mar 2022 — REGISTERED-PRINCIPAL REGISTER
- 08 Feb 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Feb 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Jan 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Dec 2021 — USE AMENDMENT FILED
- 07 Jan 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Dec 2021 — TEAS STATEMENT OF USE RECEIVED
- 18 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jun 2021 — SOU EXTENSION 4 GRANTED
- 16 Jun 2021 — SOU EXTENSION 4 FILED
- 16 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 12 Jan 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jan 2021 — SOU EXTENSION 3 GRANTED
- 08 Jan 2021 — SOU EXTENSION 3 FILED
- 08 Jan 2021 — SOU TEAS EXTENSION RECEIVED